We are live on
!
Find out more
MIU
Man Investments (UK) Portfolio holdings
AUM
$1.29B
1-Year Est. Return
31.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.56%
1 Year Est. Return
+31.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$454M
AUM Growth
–
Cap. Flow
+$448M
Cap. Flow
% of AUM
98.63%
Top 10 Holdings %
Top 10 Hldgs %
4.9%
Holding
372
New
372
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Credicorp
BAP
|
+$2.35M |
| 2 |
First American
FAF
|
+$2.2M |
| 3 |
Gentex
GNTX
|
+$2.17M |
| 4 |
Autoliv
ALV
|
+$2.15M |
| 5 |
Visteon
VC
|
+$2.14M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.67% |
| 2 | Consumer Discretionary | 19.3% |
| 3 | Industrials | 17.74% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Staples | 10.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
351
DELISTED
Celgene Corp
CELG
| $225K | 0.05% |
+3,856
| New | +$232K |
|
352
Gilead Sciences
GILD
$162B
| $223K | 0.05% |
+4,356
| New | +$227K |
|
|
LSI
353
DELISTED
LSI CORPORATION
LSI
| $222K | 0.05% |
+31,122
| New | +$213K |
|
354
Agilent Technologies
A
$39.9B
| $220K | 0.05% |
+7,187
| New | +$223K |
|
355
Amgen
AMGN
$219B
| $220K | 0.05% |
+2,229
| New | +$231K |
|
356
Perrigo
PRGO
$1.74B
| $220K | 0.05% |
+1,822
| New | +$216K |
|
357
Teradyne
TER
$60.2B
| $219K | 0.05% |
+12,475
| New | +$207K |
|
358
Thermo Fisher Scientific
TMO
$214B
| $219K | 0.05% |
+2,593
| New | +$216K |
|
359
Viatris
VTRS
$19B
| $219K | 0.05% |
+7,047
| New | +$210K |
|
360
Avnet
AVT
$7.94B
| $218K | 0.05% |
+6,488
| New | +$217K |
|
361
Microsoft
MSFT
$3.71T
| $218K | 0.05% |
+6,311
| New | +$207K |
|
362
Arrow Electronics
ARW
$11.4B
| $217K | 0.05% |
+5,434
| New | +$212K |
|
|
AXE
363
DELISTED
Anixter International Inc
AXE
| $216K | 0.05% |
+2,855
| New | +$208K |
|
364
AbbVie
ABBV
$431B
| $215K | 0.05% |
+5,192
| New | +$227K |
|
365
Alphabet (Google) Class C
GOOG
$4.36T
| $210K | 0.05% |
+9,556
| New | +$202K |
|
366
F5
FFIV
$23.5B
| $203K | 0.04% |
+2,951
| New | +$227K |
|
367
Eli Lilly
LLY
$1.06T
| $203K | 0.04% |
+4,139
| New | +$225K |
|
368
Cirrus Logic
CRUS
$6.23B
| $184K | 0.04% |
+10,626
| New | +$208K |
|
369
Vishay Intertechnology
VSH
$5.03B
| $179K | 0.04% |
+12,858
| New | +$176K |
|
|
BRCD
370
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $178K | 0.04% |
+30,876
| New | +$172K |
|
|
RVBD
371
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $178K | 0.04% |
+11,452
| New | +$176K |
|
|
PLCM
372
DELISTED
POLYCOM INC
PLCM
| $174K | 0.04% |
+16,531
| New | +$180K |
|
Similar funds
BII
WFM
SCM
SR
CH
WTIM
FOAM
HGI
Man Investments (UK)'s Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Man Investments (UK), which disclosed 372 positions worth $454M. Its ten largest holdings account for 4.9% of the portfolio.
Its largest position is Credicorp: 16,890 shares worth $2.08M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, followed by Consumer Discretionary and Industrials.
- Man Investments (UK)'s largest Q2 2013 buy was Credicorp: 16,890 shares worth $2.08M.
- Man Investments (UK)'s ten largest holdings make up 4.9% of its $454M portfolio in Q2 2013.
- Man Investments (UK) disclosed 372 positions in Q2 2013, its first 13F filing on record.
Based on Man Investments (UK)'s 13F filing for Q2 2013, filed 14 Aug 2013.